Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.

Author: AsinJerryll, CarterLawrence P, ChenDan, DonjacourClaire E H M, JanssenHennie, LammersGert Jan, OvereemSebastiaan, RamaekersJohannes G, VermeerenAnnemiek, VinckenboschFrederick, VonkPatty E, WangGrace, ZhouKefei, de VriesNicolaas

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To evaluate the impact of solriamfetol, a dopamine and norepinephrine reuptake inhibitor, on on-the-road driving in participants with excessive daytime sleepiness (EDS) associated with obstructive sleep apnoea (OSA). METHODS: Eligible participants were aged 21-75 years with OSA and EDS (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788130/

データ提供:米国国立医学図書館(NLM)

Solriamfetol: A Potential Solution for Sleep Apnea and Driving Safety

This research dives into the realm of sleep disorders, a world as vast and intricate as the Sahara desert. The study investigates the effects of solriamfetol, a medication used to treat excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA), on driving performance. The researchers aimed to determine if solriamfetol could improve driving safety for individuals struggling with OSA and EDS. This research is particularly relevant to the safety of drivers and those with sleep disorders.

Solriamfetol: A Potential Driving Safety Aid

The researchers found that solriamfetol significantly improved on-the-road driving performance in participants with EDS associated with OSA. These findings suggest that solriamfetol may be a valuable tool for improving driving safety for individuals with these conditions.

Sleep Apnea and Driving Safety

This research highlights the importance of addressing sleep disorders, particularly OSA, to enhance driving safety. The study suggests that appropriate treatment and management of sleep disorders can contribute to safer roads and reduced risk of accidents.

Dr.Camel's Conclusion

This research serves as a reminder that the journey to a safe and healthy life often requires a multi-faceted approach. Just as a desert traveler must be prepared for the challenges of the arid landscape, those with sleep disorders and other health conditions should be proactive in seeking appropriate treatment and support. This study provides valuable insights into the potential role of solriamfetol in improving driving safety for individuals with OSA and EDS.

Date :
  1. Date Completed 2022-10-31
  2. Date Revised 2022-12-29
Further Info :

Pubmed ID

35633275

DOI: Digital Object Identifier

PMC9788130

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.